This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
Source ↗
👁 2
💬 0
The post This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie appeared first on 24/7 Wall St..
AbbVie (ABBV) posted Q1 revenue of $15.002B (beating consensus by $284M) with a 65.4% free cash flow payout ratio and 13-year dividend streak, supporting its 2.98% yield.
Skyrizi and Rinvoq are replacing low-margin Humira faster than exp
AbbVie (ABBV) posted Q1 revenue of $15.002B (beating consensus by $284M) with a 65.4% free cash flow payout ratio and 13-year dividend streak, supporting its 2.98% yield.
Skyrizi and Rinvoq are replacing low-margin Humira faster than exp
Comments (0)